Suchergebnisse - "Senni, Michele"

PubPharm (474)

11

Potential proarrhythmic side effect of high dose and prolonged infusion of sodium nitroprusside through calcium ion reduction : a case report

enthalten in: European heart journal. Case reports | 2024

von Fazzini, L. | Gori, M. | Dessalvi, C. | +1

12

The Therapy and Management of Heart Failure with Preserved Ejection Fraction : New Insights on Treatment

enthalten in: Cardiac failure review | 2024

von Balestrieri, G. | Limonta, R. | Ponti, E. | +8

13

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

enthalten in: European Journal of Heart Failure | 2024

von Bertero, E. | Chiti, C. | Schiavo, M. | +60

14

Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban

enthalten in: Journal of clinical medicine | 2023

von Mapelli, M. | Mattavelli, I. | Salvioni, E. | +38

15

Iatrogenic Left Atrial Dissection After a Percutaneous Coronary Revascularization : Challenges and Management Strategies

enthalten in: Circulation. Cardiovascular imaging | 2023

von Fazzini, L. | Gori, M. | Canova, P. | +7

16

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

enthalten in: Journal of the American College of Cardiology | 2023

von Butler, J. | Abildstrøm, S. | Borlaug, B. | +21

CommentIn: J Am Coll Cardiol. 2023 Nov 28;82(22):2097-2100. - PMID 37993202

17

Heart failure patients with improved ejection fraction : Insights from the MECKI score database

enthalten in: European journal of heart failure | 2023

von Agostoni, P. | Pluchinotta, F. | Salvioni, E. | +49

18

The STEP-HFpEF trial : proof of concept that phenotypic therapy in heart failure with preserved ejection fraction can really be a valid therapeutic solution?

enthalten in: Giornale italiano di cardiologia (2006) | 2023

von Senni, M. | Sciatti, E.

19

Practical patient care appraisals with use of new potassium binders in heart failure and chronic kidney diseases

enthalten in: Journal of cardiovascular medicine (Hagerstown, Md.) | 2023

von Senni, M. | Sciatti, E. | Bussalino, E. | +3

20

Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease : The Beta3-LVH Phase 2b Randomized Clinical Trial

enthalten in: JAMA cardiology | 2023

von Balligand, J. | Brito, D. | Brosteanu, O. | +25